We found it! The venture rebound
VCs may worry that too much cash is chasing too few good deals. But for entrepreneurs in a few key sectors, it's springtime for funding.
By Ellen Florian FORTUNE
May 3, 2004 issue
|
Below, some highlights of the five sectors getting the most venture funding, and a list of the most active venture investors in 2003.
Connectivity/Communications Tools Accel Partners, Intel Capital, and Microsoft are sharing in the latest round (a $38 million bet) for Beverly, Mass.-based Groove Networks, whose peer-to-peer technology creates secure, virtual workspaces that can be used by widely dispersed people. The Homeland Security Information Network uses Groove software.
| Recently Funded |
$ Latest Round |
Lead Investor |
| Sonim Technologies |
$28 million |
Accel Partners |
| CipherTrust |
$42 million |
Battery Ventures, Greylock |
Biotechnology Favrille, a four-year-old, San Diego-based biotech that is developing a personalized cancer treatment made from a patient's own tumors, secured $44 million in funding in April. Two days later the company registered with the SEC for an initial public offering. In 2003 the company lost $13.3 million.
| Recently Funded |
$ Latest Round |
Lead Investor |
| Renovis |
$45 million |
Easton Hunt Capital Partners |
| Accorda Therapeutics |
$11.5 million |
Not disclosed |
Nonfinancial Business Services Menlo Ventures, NEA, Alloy Ventures, and Deutsche Post Ventures handed over $20 million-plus in funding for Open Harbor. The San Carlos, Calif., company's software helps global businesses deal with ever-changing worldwide trade regulations. DHL is standardizing its customs processes with Open Harbor's software.
| Recently Funded |
$ Latest Round |
Lead Investor |
| MarkMonitor |
$22 million |
Institutional Venture Partners |
| 180solutions |
$40 million |
Spectrum Equity Investors |
Pharmaceuticals CoTherix, the company formerly known as Exhale Therapeutics, raised a hefty $55 million this past fall around the same time it changed its name, got a new CEO, and acquired the rights to Berlin-based Schering AG's Ventavis, which treats pulmonary hypertension. A few weeks ago the company filed an IPO. One serious risk factor listed in the offering: no current source of product revenue.
| Recently Funded |
$ Latest Round |
Lead Investor |
| Critical Therapeutics |
$56 million |
Advanced Technology Ventures, Johnson & Johnson Development |
| Hypnion |
$47.5 million |
Forward Ventures, MPM Capital |
Application-Specific Integrated Circuits Mobius Venture Capital led a top-tier venture team to pony up $60 million last summer for Infinera, a startup that's quietly developing a low-cost optical chip for the telecom industry. So far Infinera has hit up investors for $130 million. Venture capitalist Vinod Khosla of Kleiner Perkins is a board member.
| Recently Funded |
$ Latest Round |
Lead Investor |
| Matrix Semiconductor |
$52 million |
TeleSoft Partners |
| Ikanos Communications |
$33 million |
TL Ventures |
| The Most Active Venture Investors in 2003 |
|
Investor |
Location |
No. of deals |
| 1 |
New Enterprise Associates |
Baltimore |
73 |
| 2 |
Draper Fisher Jurvetson |
Menlo Park, Calif. |
52 |
| 3 |
Sevin Rosen Funds |
Dallas |
50 |
| 4 |
Polaris Venture Partners |
Waltham, Mass. |
48 |
| 5 |
U.S. Venture Partners |
Menlo Park, Calif. |
47 |
| 6 |
Intel Capital |
Santa Clara, Calif. |
43 |
| 7 |
Mobius Venture Capital |
Palo Alto |
43 |
| 8 |
Austin Ventures |
Austin |
42 |
| 9 |
Warburg Pincus |
New York |
42 |
| 10 |
Venrock Associates |
New York |
40 |
| 11 |
Advanced Tech. Ventures |
Waltham, Mass. |
38 |
| 12 |
Mayfield |
Menlo Park, Calif. |
37 |
| 13 |
St. Paul Venture Capital |
Eden Prairie, Minn. |
37 |
| 14 |
J.P. Morgan Partners |
New York |
35 |
| 15 |
TL Ventures |
Wayne, Pa. |
35 |
|
| Source: PricewaterhouseCoopers/Venture Economics/NVCA MoneyTree Survey |
Reporter Associate(s): Doris Burke
|